Administration of radium‐223 and the prognosis in Japanese bone metastatic castration‐resistant prostate cancer patients: A large database study.

MLA

Kawahara, Takashi, et al. “Administration of Radium‐223 and the Prognosis in Japanese Bone Metastatic Castration‐resistant Prostate Cancer Patients: A Large Database Study.” International Journal of Urology, vol. 29, no. 9, Sept. 2022, pp. 1079–84. EBSCOhost, https://doi.org/10.1111/iju.15008.

APA

Kawahara, T., Miyoshi, Y., Ninomiya, S., Sato, M., Takeshima, T., Hasumi, H., Makiyama, K., & Uemura, H. (2022). Administration of radium‐223 and the prognosis in Japanese bone metastatic castration‐resistant prostate cancer patients: A large database study. International Journal of Urology, 29(9), 1079–1084. https://doi.org/10.1111/iju.15008

Chicago

Kawahara, Takashi, Yasuhide Miyoshi, Sahoko Ninomiya, Motoki Sato, Teppei Takeshima, Hisashi Hasumi, Kazuhide Makiyama, and Hiroji Uemura. 2022. “Administration of Radium‐223 and the Prognosis in Japanese Bone Metastatic Castration‐resistant Prostate Cancer Patients: A Large Database Study.” International Journal of Urology 29 (9): 1079–84. doi:10.1111/iju.15008.